↓ Skip to main content

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

Overview of attention for article published in Alzheimer's Research & Therapy, March 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
2 X users
patent
1 patent

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
188 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
Published in
Alzheimer's Research & Therapy, March 2020
DOI 10.1186/s13195-020-00596-4
Pubmed ID
Authors

Nicolas R. Barthélemy, Randall J. Bateman, Christophe Hirtz, Philippe Marin, François Becher, Chihiro Sato, Audrey Gabelle, Sylvain Lehmann

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 188 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 18%
Student > Ph. D. Student 29 15%
Student > Master 18 10%
Student > Bachelor 10 5%
Professor 8 4%
Other 18 10%
Unknown 71 38%
Readers by discipline Count As %
Neuroscience 33 18%
Medicine and Dentistry 16 9%
Biochemistry, Genetics and Molecular Biology 15 8%
Chemistry 5 3%
Agricultural and Biological Sciences 5 3%
Other 26 14%
Unknown 88 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2022.
All research outputs
#1,307,183
of 23,198,445 outputs
Outputs from Alzheimer's Research & Therapy
#177
of 1,259 outputs
Outputs of similar age
#35,784
of 394,057 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#5
of 33 outputs
Altmetric has tracked 23,198,445 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,259 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 394,057 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.